New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
08:56 EDTLCILannett decline on Connecticut probe seems overdone, says Roth Capital
After Lannett fell 17% following the disclosure that it had received subpoenas from Connecticut regarding the pricing of digoxin, Roth Capital does not expect the state to take any further action against the company. The firm does not believe that there has been any collusion on digoxin prices. It keeps a $45 price target and Buy rating on the shares.
News For LCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
07:56 EDTLCILannett sees Q1 EPS 91c-94c, consensus 77c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use